Effects of thyroid hormones on human breast cancer cell proliferation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 1-2, 2008, Pages 57-66

  Hall, Linda C ^a   Salazar, Eddie P ^a   Kane, Staci R ^a   Liu, Nan ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Breast cancer; Cell proliferation; Gene expression; Thyroid hormone

Indexed keywords

ESTRADIOL; LIOTHYRONINE; LUCIFERASE; THYROID HORMONE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; HUMAN; HUMAN CELL;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION; GENES, REPORTER; HUMANS; LUCIFERASES; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE;

EID: 40849089181     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.12.008     Document Type: Article

References (41)

1. Oppenheimer J., Schwartz H., and Strait K. The Molecular Basis of Thyroid Hormone Actions (1996), Lippincott-Raven Publishers, Philadelphia
2. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-1142
3. Couse J.F., and Korach K.S. Contrasting phenotypes in reproductive tissues of female estrogen receptor null mice. Ann. N. Y. Acad. Sci. 948 (2001) 1-8
4. Britt K.L., and Findlay J.K. Estrogen actions in the ovary revisited. J. Endocrinol. 175 (2002) 269-276
5. Hewitt S.C., and K.S., and Korach. Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction 125 (2003) 143-149
6. Matthews J., and Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 3 (2003) 281-292
7. Mori T., Nagasawa H., and Bern H.A. Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review. J. Environ. Pathol. Toxicol. 3 (1979) 191-205
8. Muhlbock O. Role of hormones in the etiology of breast cancer. J. Natl. Cancer Inst. 48 (1972) 1213-1216
9. Cotterchio M., Kreiger N., Theis B., Sloan M., and Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1053-1060
10. Colditz G.A., Rosner B.A., Chen Holmes W.Y., and Hankinson M.D.S.E. Risk factors for breast cancer according to estrogen and progesterone receptor status. J. Natl. Cancer Inst. 96 (2004) 218-228
11. Fisher B. A vignette from breast cancer history: one hundred years after the Greenough report. J. Am. Coll. Surg. 200 (2005) 484-486
12. Silva J.M., Dominguez G., Gonzalez-Sancho J.M., Garcia J.M., Silva J., Garcia-Andrade C., Navarro A., Munoz A., and Bonilla F. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 21 (2002) 4307-4316
13. Conde I., Paniagua R., Zamora J., Blanquez M.J., Fraile B., Ruiz A., and Arenas M.I. Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann. Oncol. 17 (2006) 60-64
14. Neville M.C., McFadden T.B., and Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia 7 (2002) 49-66
15. Li Z., Meng Z.H., Chandrasekaran R., Kuo W.L., Collins C.C., Gray J.W., and Dairkee S.H. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. Cancer Res. 62 (2002) 1939-1943
16. Cristofanilli M., Yamamura Y., Kau S.W., Bevers T., Strom S., Patangan M., Hsu L., Krishnamurthy S., Theriault R.L., and Hortobagyi G.N. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103 (2005) 1122-1128
17. Saraiva P.P., Figueiredo N.B., Padovani C.R., Brentani M.M., and Nogueira C.R. Profile of thyroid hormones in breast cancer patients. Braz. J. Med. Biol. Res. 38 (2005) 761-765
18. Smyth P.P. The thyroid and breast cancer: a significant association?. Ann. Med. 29 (1997) 189-191
19. Smyth P.P., Smith D.F., McDermott E.W., Murray M.J., Geraghty J.G., and O'Higgins N.J. A direct relationship between thyroid enlargement and breast cancer. J. Clin. Endocrinol. Metab. 81 (1996) 937-941
20. Zhou-Li F., Skalli M., Albaladejo V., Joly-Pharaboz M.O., Nicolas B., and Andre J. Interference between estradiol and l-triiodothyronine in the control of the proliferation of a pituitary tumor cell line. J. Steroid Biochem. Mol. Biol. 45 (1993) 275-279
21. Dinda S., and Sanchez A.V. Moudgil Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21 (2002) 761-768
22. Barrera-Hernandez G., Park K.S., Dace A., Zhan Q., and Cheng S.Y. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 140 (1999) 5267-5274
23. Klinge C.M., Jernigan S.C., Mattingly K.A., Risinger K.E., and Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 33 (2004) 387-410
24. Gruber C.J., Gruber D.M., Gruber I.M., Wieser F., and Huber J.C. Anatomy of the estrogen response element. Trends Endocrinol. Metab. 15 (2004) 73-78
25. Alarid E.T., Preisler-Mashek M.T., and Solodin N.M. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144 (2003) 3469-3476
26. Gougelet S.O., Mueller K.S., Korach J.M., and Renoir. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. J. Steroid Biochem. Mol. Biol. 104 (2007) 110-122
27. Matthews J., Wihlen B., Tujague M., Wan J., Strom A., and Gustafsson J.A. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol. Endocrinol. 20 (2006) 534-543
28. Hodin R.A., Lazar M.A., and Chin W.W. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J. Clin. Invest. 85 (1990) 101-105
29. Schwartz H.L., Lazar M.A., and Oppenheimer J.H. Widespread distribution of immunoreactive thyroid hormone beta 2 receptor (TR beta 2) in the nuclei of extrapituitary rat tissues. J. Biol. Chem. 269 (1994) 24777-24782
30. Pettersson K., and Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63 (2001) 165-192
31. Power K.A., and Thompson L.U. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation. Breast Cancer Res. Treat. 81 (2003) 209-221
32. Martinez M.B., Ruan M., and Fitzpatrick L.A. Altered response to thyroid hormones by prostate and breast cancer cells. Cancer Chemother. Pharmacol. 45 (2000) 93-102
33. Nogueira C.R., and Brentani M.M. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J. Steroid Biochem. Mol. Biol. 59 (1996) 271-279
34. Zhou-Li F., Albaladejo V., Joly-Pharaboz M.O., Nicolas B., and Andre J. Antiestrogens prevent the stimulatory effects of l-triiodothyronine on cell proliferation. Endocrinology 130 (1992) 1145-1152
35. Tang H.Y., Lin H.Y., Zhang S., Davis F.B., and Davis P.J. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145 (2004) 3265-3272
36. Fujimoto N., Jinno N., and Kitamura S. Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3. J. Endocrinol. 181 (2004) 77-83
37. Bassett J.H., Harvey C.B., and Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 213 (2003) 1-11
38. Dellovade T.L., Zhu Y.S., and Pfaff D.W. Potential interactions between estrogen receptor and thyroid receptors relevant for neuroendocrine systems. J. Steroid Biochem. Mol. Biol. 53 (1995) 27-31
39. Davis P.J., Shih A., Lin H.Y., Martino L.J., and Davis F.B. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J. Biol. Chem. 275 (2000) 38032-38039
40. Shih A., Lin H.Y., Davis F.B., and Davis P.J. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40 (2001) 2870-2878
41. Bartek J., Bartkova J., and Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237 (1997) 1-6